Michael Reclaims Box Office Top Spot

Premium screens put Michael back in command of the box office, underscoring how much large-format and high-priced tickets now shape a film’s staying power.

Lionsgate’s Michael Jackson biopic returned to No. 1 after drawing renewed momentum from Imax and other premium auditoriums, according to reports. The result keeps the film’s strong theatrical run alive and reinforces its status as a major commercial force. At the same time, The Devil Wears Prada 2 continued to hold firm near the top of the chart and crossed the $500 million mark globally on Friday, giving theaters another high-performing title as the market looks for consistency.

Premium screens did more than boost ticket prices — they helped reshape the weekend’s leaderboard.

The weekend also delivered a fresh success story. Curry Barker’s Obsession opened in third place with a reported $15 million, a solid start that suggests room for growth if audience interest holds. In a crowded marketplace, that kind of opening matters. It signals that moviegoers still show up for new entries when a title cuts through the noise, even as bigger films continue to dominate the top slots.

Key Facts

  • Michael returned to No. 1 at the box office.
  • Imax and other premium screens helped drive the film’s rebound.
  • The Devil Wears Prada 2 passed $500 million worldwide on Friday.
  • Obsession opened in third place with a reported $15 million.

Taken together, the weekend points to a box office split between staying power and fresh demand. One film used premium formats to regain momentum, another kept building on global appeal, and a new release arrived with enough force to earn attention of its own. That mix gives exhibitors a stronger lineup than a one-hit market can offer.

What happens next will test whether premium-screen momentum can keep Michael on top and whether Obsession can turn a strong opening into a durable run. For studios and theater owners, the stakes go beyond one weekend: the current chart shows that format strategy, franchise endurance, and smart release timing all matter in a market still chasing reliable theatrical wins.